355 related articles for article (PubMed ID: 36466856)
1. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E
Front Immunol; 2022; 13():942493. PubMed ID: 36466856
[TBL] [Abstract][Full Text] [Related]
2. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.
Karsten CM; Beckmann T; Holtsche MM; Tillmann J; Tofern S; Schulze FS; Heppe EN; Ludwig RJ; Zillikens D; König IR; Köhl J; Schmidt E
Front Immunol; 2018; 9():488. PubMed ID: 29599777
[TBL] [Abstract][Full Text] [Related]
3. Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.
Pigors M; Patzelt S; Reichhelm N; Dworschak J; Khil'chenko S; Emtenani S; Bieber K; Hofrichter M; Kamaguchi M; Goletz S; Köhl G; Köhl J; Komorowski L; Probst C; Vanderheyden K; Balbino B; Ludwig RJ; Verheesen P; Schmidt E
J Pathol; 2024 Feb; 262(2):161-174. PubMed ID: 37929639
[TBL] [Abstract][Full Text] [Related]
4. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
Sadik CD; Miyabe Y; Sezin T; Luster AD
Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
7. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
[TBL] [Abstract][Full Text] [Related]
8. The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid.
Heimbach L; Li Z; Berkowitz P; Zhao M; Li N; Rubenstein DS; Diaz LA; Liu Z
J Biol Chem; 2011 Apr; 286(17):15003-9. PubMed ID: 21393236
[TBL] [Abstract][Full Text] [Related]
9. C5aR2 Deficiency Ameliorates Inflammation in Murine Epidermolysis Bullosa Acquisita by Regulating Fcγ Receptor Expression on Neutrophils.
Seiler DL; Kleingarn M; Kähler KH; Gruner C; Schanzenbacher J; Ehlers-Jeske E; Kenno S; Sadik CD; Schmidt E; Bieber K; Köhl J; Ludwig RJ; Karsten CM
J Invest Dermatol; 2022 Oct; 142(10):2715-2723.e2. PubMed ID: 35007559
[TBL] [Abstract][Full Text] [Related]
10. C5aR2 receptor: The genomic twin of the flamboyant C5aR1.
Das A; Gupta PK; Rana S
J Cell Biochem; 2022 Nov; 123(11):1841-1856. PubMed ID: 35977039
[TBL] [Abstract][Full Text] [Related]
11. In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases.
Moriuchi R; Nishie W; Ujiie H; Natsuga K; Shimizu H
J Dermatol Sci; 2015 Apr; 78(1):21-5. PubMed ID: 25724363
[TBL] [Abstract][Full Text] [Related]
12. The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.
Seiler DL; Kähler KH; Kleingarn M; Sadik CD; Bieber K; Köhl J; Ludwig RJ; Karsten CM
Front Immunol; 2023; 14():1197709. PubMed ID: 37275893
[TBL] [Abstract][Full Text] [Related]
13. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
14. Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.
Das A; Ghosh M; Gupta PK; Rana S
J Cell Biochem; 2023 Feb; 124(2):266-281. PubMed ID: 36565188
[TBL] [Abstract][Full Text] [Related]
15. The Novel Receptor C5aR2 Is Required for C5a-Mediated Human Mast Cell Adhesion, Migration, and Proinflammatory Mediator Production.
Pundir P; MacDonald CA; Kulka M
J Immunol; 2015 Sep; 195(6):2774-87. PubMed ID: 26283482
[TBL] [Abstract][Full Text] [Related]
16. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
[TBL] [Abstract][Full Text] [Related]
17. Differential Contributions of the Complement Anaphylotoxin Receptors C5aR1 and C5aR2 to the Early Innate Immune Response against Staphylococcus aureus Infection.
Horst SA; Itzek A; Klos A; Beineke A; Medina E
Pathogens; 2015 Oct; 4(4):722-38. PubMed ID: 26512700
[TBL] [Abstract][Full Text] [Related]
18. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Li XX; Clark RJ; Woodruff TM
Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
[TBL] [Abstract][Full Text] [Related]
19. The C5a/C5aR2 axis promotes renal inflammation and tissue damage.
Zhang T; Wu KY; Ma N; Wei LL; Garstka M; Zhou W; Li K
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32191644
[TBL] [Abstract][Full Text] [Related]
20. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM
J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]